Cargando…
Elevated Th22 as well as Th17 cells associated with therapeutic outcome and clinical stage are potential targets in patients with multiple myeloma
T helper (Th) cell imbalance plays important roles in tumor development and their effects in Multiple myeloma (MM) remain unclear. In the present study, we investigated the levels and clinical significance of Th22, Th17 and Th1 cells in patients with MM. Th subsets were examined by flow cytometry. P...
Autores principales: | Wang, Min, Chen, Ping, Jia, Yan, He, Na, Li, Daqi, Ji, Chunyan, Ma, Daoxin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4627228/ https://www.ncbi.nlm.nih.gov/pubmed/26255628 |
Ejemplares similares
-
The Alteration and Clinical Significance of Th22/Th17/Th1 Cells in Patients with Chronic Myeloid Leukemia
por: Chen, Ping, et al.
Publicado: (2015) -
Elevated Th22 Cells Correlated with Th17 Cells in Peripheral Blood of Patients with Acute Myeloid Leukemia
por: Yu, Shuang, et al.
Publicado: (2014) -
Circulating Th22 cells, as well as Th17 cells, are elevated in patients with renal cell carcinoma
por: Peng, Zhiguo, et al.
Publicado: (2021) -
Th22 Cells as Well as Th17 Cells Expand Differentially in Patients with Early-Stage and Late-Stage Myelodysplastic Syndrome
por: Shao, Lin-lin, et al.
Publicado: (2012) -
The existence of Th22, pure Th17 and Th1 cells in CIN and Cervical Cancer along with their frequency variation in different stages of cervical cancer
por: Zhang, Wenjing, et al.
Publicado: (2015)